Sector: Pharmaceuticals & Biotechnology

Small Cap

Ind-Swift Laboratories Share Price

INDSWFTLAB

₹325.35

-4.24(-1.29%)

24th Aug 2026 | 3:28 PM

NSE : INDSWFTLAB

Open Free Demat Account

Ind-Swift Laboratories Performance

Price Movement

₹325.35

₹316.61

₹332.31

↘ Today's Low↗ Today's High

1 Year Performance

₹325.35

₹87.15

₹351.30

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹332.31

Low₹316.61

Open at₹329.59

Prev Close₹329.59

Volumes4.33 L

Avg Price₹325.80

Lower Circuit₹263.68

Upper Circuit₹395.50

Historical Performance

3M High₹351.30

3M Low₹129.50

1 Yr High₹351.30

1 Yr Low₹87.15

3 Yr High₹351.30

3 Yr Low₹68.72

5 Yr High₹351.30

5 Yr Low₹52.65

Summary

As of 25-08-2026 02:00, Ind-Swift Laboratories Ltd. share price today is ₹0, with a change of ₹-329.59 (-100.00%) from the previous close of ₹329.59. The stock opened at ₹329.59 and traded between ₹316.61 and ₹332.31, with a total traded volume of 433051 shares. The company has a market capitalization of ₹2866.2 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹351.3 and ₹87.15, respectively.

Ind-Swift Laboratories Ltd. valuation metrics include a P/E ratio of 50, EPS of ₹4.95, and book value of ₹2.00. Profitability indicators show ROE of 2.99%. Ind-Swift Laboratories Ltd. has reported revenue of ₹664.74 Cr and net profit of ₹57.32 Cr.

Ind-Swift Laboratories Ltd. technical indicators include Day RSI at 72.07, Day MFI at 86.82, Day ADX at 46.73. Additional indicators include Commodity Channel Index (CCI) at 102.9 and Williams %R at -17.19. Momentum indicators show Day MACD at 30.17, Day MACD Signal Line at 23.25, DayATR at 17.62. Rate of Change indicators for Ind-Swift Laboratories Ltd. include ROC125 at 129.47 and ROC21 at 45.84.

Exponential moving averages include EMA5 at ₹324.2, EMA10 at ₹306.8, EMA12 at ₹300.6, EMA20 at ₹281.2, EMA26 at ₹270.4, EMA50 at ₹240, EMA100 at ₹203.9, EMA200 at ₹169. Simple moving averages include SMA5 at ₹329, SMA10 at ₹306.8, SMA20 at ₹267.8, SMA30 at ₹255.8, SMA50 at ₹232.6, SMA100 at ₹187.5, SMA150 at ₹168.2, SMA200 at ₹150.1.

Support levels for Ind-Swift Laboratories are placed at First Support ₹324.00, Second Support ₹318.41, Third Support ₹311.61. Resistance levels are seen at First Resistance ₹336.39, Second Resistance ₹343.19, Third Resistance ₹348.78. Ind-Swift Laboratories Ltd. shareholding pattern shows promoter holding at 42.93%, FII holding at 10.7%, DII holding at 0%, public holding at 46.19%.

Ind-Swift Laboratories Fundamentals

Market Cap

Above industry Median

2,866.20 Cr.

PE Ratio (TTM)

Above industry Median

Dividend Yield

Net Profit TTM

75% decr over last year

57.32

Net Profit Growth

75% decr over last year

57.32

PEG Ratio

Negative PEG TTM

-0.70

ROE

86% decr over last year

2.99

Operating Revenue TTM

664.74

Operating Revenue Growth

113.3% incr over last year

Book Value

Below industry Median

MFI

MFI strongly Overbought

86.82

RSI

RSI Overbought

72.07

EPS (TTM)

4.95

Debt to Equity

0.01

Face Value

Operating Profit Margin Qtr.

6.55

Operating Profit Qtr.

33.43

Net Profit Qtr.

24.68

Operating Revenue Qtr.

191.45

PB Ratio

Ind-Swift Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	186.08	172.70	149.48	150.44	147.99
Operating Expense	152.76	152.40	144.08	148.25	144.92
Operating Profit	33.32	20.30	5.40	2.19	3.07
Depreciation	7.58	8.08	8.84	6.98	6.68
Interest	0.71	-2.44	0.67	2.01	1.15
Tax	7.98	-3.22	6.87	2.30	1.71
Net Profit	24.44	14.94	10.74	8.76	8.12

Ind-Swift Laboratories Technicals

Ind-Swift Laboratories Ltd. EMA & SMA

₹325.35

-8.16 (-2.45%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹324.2

Day EMA10 ₹306.8

Day EMA12 ₹300.6

Day EMA20 ₹281.2

Day EMA26 ₹270.4

Day EMA50 ₹240

Day EMA100 ₹203.9

Day EMA200 ₹169

Ind-Swift Laboratories Support and Resistance

Resistance

First Resistance₹336.39

Second Resistance₹343.19

Third Resistance₹348.78

Support

First Support₹324.00

Second Support₹318.41

Third Support₹311.61

Technical Indicators

Day RSI72.07

Day MFI86.82

Day ADX46.73

Day Commodity Channel Index102.90

William-17.19

Day MACD30.17

Day MACD Signal Line23.25

Day ATR17.62

Day ROC125129.47

Day ROC2145.84

Ind-Swift Laboratories Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	40.9	40.9	39.5	39.5	43	42.9
FII	3.1	4.3	14.8	14.3	13.9	10.7
DII	0.9	0.9	0.7	0.7	0	0.2
Public	55.1	53.9	45	45.5	43.1	46.2

Ind-Swift Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.6 L	3.86 L	41.55%
Week	6.7 L	21.72 L	30.86%
1 Month	4.93 L	17.23 L	28.59%
6 Month	5.39 L	13.93 L	38.73%

Ind-Swift Laboratories SWOT Analysis

Strengths28

Weakness13

Opportunity0

Threats0

Benjamin Graham Value Screen

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Expensive Rockets (DVM)

Relative Outperformance versus Industry over 1 Month

Momentum Play Screener - Weekly Screener

Relative Outperformance versus Industry over 1 Year

Stringent DVM Screener

Weekly Screener: High Momentum Score Stocks (subscription)

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Companies with rising net profit margins - quarterly as well as TTM basis

Overbought by Money Flow Index (MFI)

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing profits every quarter for the past 3 quarters

Increasing Revenue every quarter for the past 2 quarters

Companies with Zero Promoter Pledge

Near 52 Week High

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Ind-Swift Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Instrument Type
20 Sep, 2011	1	FINAL	Equity Share
16 Sep, 2010	1	FINAL	Equity Share
17 Sep, 2009	1	FINAL	Equity Share
18 Sep, 2008	1	FINAL	Equity Share
21 Sep, 2007	1	FINAL	Equity Share
22 Sep, 2006	1.5	FINAL	Equity Share
22 Sep, 2005	1.5	FINAL	Equity Share
23 Sep, 2004	1	FINAL	Equity Share

Ind-Swift Laboratories Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Valiant Laboratories Ltd.
Price (₹)	₹526.25	₹6.55	₹205.20	₹15.46	₹518.70	₹100.52
% Change	-2.70%	4.97%	4.81%	8.26%	-3.29%	4.99%
Revenue TTM (₹ Cr)	₹526.28	₹69.99	₹291.17	₹226.23	₹511.48	₹305.93
Net Profit TTM (₹ Cr)	₹20.77	₹-176.47	₹14.68	₹31.63	₹53.97	₹16.01
PE TTM	115.10	-0.30	51.80	2.40	28.70	32.50
1 Year Return	37.97	524	55.39	56.92	-23.59	8.81
ROCE	3.56	-56.37	-	17.36	23.87	0.77

Similar Stocks

SIGACHI

Sigachi Industries Ltd.

₹ 30.45

+1.33%

WINDLAS

Windlas Biotech Ltd.

₹ 988.00

-0.56%

VINEETLAB

Vineet Laboratories Ltd.

₹ 37.00

-2.14%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 628.00

+1.80%

ZIMLAB

Zim Laboratories Ltd.

₹ 124.16

-0.70%

MEDICO

Medico Remedies Ltd.

₹ 42.09

-1.31%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 173.00

-0.31%

LASA

Lasa Supergenerics Ltd.

₹ 7.33

+1.81%

HALEOSLABS

Haleos Labs Ltd.

₹ 1500.00

+2.39%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 302.20

+0.73%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 322.00

+0.00%

ORTINGLOBE

Ortin Global Ltd.

₹ 15.26

-3.96%

BROOKS

Brooks Laboratories Ltd.

₹ 61.70

+2.83%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2638.00

+0.05%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 254.55

+4.99%

ALPA

Alpa Laboratories Ltd.

₹ 61.20

-2.47%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 354.00

-0.73%

NECLIFE

Nectar Lifesciences Ltd.

₹ 10.80

+3.15%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 30.44

+9.97%

INDOCO

Indoco Remedies Ltd.

₹ 220.00

-2.78%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 612.00

-0.33%

PANACEABIO

Panacea Biotec Ltd.

₹ 406.50

-1.12%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 234.00

-4.31%

THEMISMED

Themis Medicare Ltd.

₹ 120.50

+13.53%

FAQ's on INDSWFTLAB

What is the current share price of Ind-Swift Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Ind-Swift Laboratories Ltd. is ₹ 325.35 on the NSE and ₹ 327.75 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Ind-Swift Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Ind-Swift Laboratories Ltd. is approximately ₹ 2866.2 Cr.

What are the PE and PB ratios for Ind-Swift Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Ind-Swift Laboratories Ltd. is 50, and the Price-to-Book (PB) ratio is 2.

What is the 52-Week High and Low for Ind-Swift Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Ind-Swift Laboratories Ltd. shares was ₹ 351.3, and the lowest price was ₹ 87.15.

Who are the major shareholders of Ind-Swift Laboratories Ltd.?

Significant shareholdings in Ind-Swift Laboratories Ltd. typically include entities such as:

Public
Promoter
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Ind-Swift Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Ind-Swift Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Ind-Swift Laboratories Ltd.?

Ind-Swift Laboratories Ltd. last declared a FINAL dividend of ₹ 1 per share for the financial period ending 2011. The record date was set as 2011-09-20, and the payment was/is scheduled around 2011-09-20. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy